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(P=0.2), whereas it continued to show benefit in the group with
LVEF of 40%–49% (P=0.001).
Conclusion: Clinical predictors of mortality in patients with
transient LV systolic dysfunction may help further risk-stratify
this cohort of patients. It appears that patients with LVEF of
40%–49% continue to derive benefit from ICD therapy.
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Background: An estimated 51,000 health care-associated
Pseudomonas aeruginosa infections occur in the United States
annually. More than 13% are secondary to non-carbapenem
multidrug-resistant strains, which result in 400 yearly deaths.
Traditional risk factors for resistance include ICU stay,
mechanical ventilation, previous hospitalization and major
comorbidities. As microbes evolve, risk factors also may
evolve.
Purpose: To determine if traditional and/or new risk factors for
P. aeruginosa resistance are valid and predictive of infection
with carbapenem-resistant P. aeruginosa.
Methods: We retrospectively studied inpatients and outpatients
≥ 18 years old who presented to an Aurora Health Care facility
with a positive P. aeruginosa culture during 2014. Cultures
were obtained from the ACL Laboratories database, and patient
medical records were reviewed in Epic. Chi-squared test with
Yates correction and two-sample t-tests were performed on
categorical and continuous variables, respectively. Binary
regression was used for multivariable modeling. Significance
was associated with P<0.05.
Results: Study population (N=1,763) characteristics were:
mean age 68.0, body mass index 30.4 kg/m2, 51.2% female
sex, and 89.3% white race. Resistance to imipenem or
meropenem (14.0%) on univariable analysis was associated
with younger age (66.0 vs 68.3 years, P=0.027), hospitalized
patients (19.7% vs 8.6%, P<0.0001), male sex (16.0% vs
12.0%, P=0.017), nonwhite race (23.5% vs 12.3%, P<0.0001),
respiratory culture (30.9% vs 12.1%, P<0.0001), history of
pulmonary disease (19.4% vs 12.9%, P=0.005), history of
congestive heart failure (18.6% vs 13.0%, P=0.016), history
of multidrug resistance (33.3% vs 13.6%, P=0.003) and recent
surgery (17.8% vs 12.2%, P=0.002), as well as transfer from
institution, Foley catheter, vasopressor treatment, central/PIC
lines, mechanical ventilation, ICU admission, and bedridden
status (all P<0.0001). In multivariable modeling, nonwhite
race, respiratory culture, recent transfer, vasopressor use and
central/PIC lines were significant. Only 0.57% of strains were
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resistant to the six traditional non-carbapenem drugs and both
carbapenems.
Conclusion: Demographic and traditional risk factors, as well as
respiratory cultures, were predictive of carbapenem resistance.
Such information may guide initial antibiotic treatment of P.
aeruginosa. Fortunately, less than 1% of strains were resistant
to all drugs tested. Further studies looking at change in outcome
while incorporating these risk factors in determination of
empiric coverage for patients should be performed.
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Background: Preoperative risk assessments of individuals
who undergo major noncardiac surgery have focused on
ischemic heart disease. Information on how to assess the
noncardiac surgical risks for patients with depressed cardiac
function, as seen in heart failure, is sparse. Echocardiography is
routinely performed in patients with depressed cardiac function
and is an accepted standard cardiac assessment. Transthoracic
echocardiography (TTE) provides strong independent
prognostic implications in a wide range of cardiovascular
conditions.
Purpose: To identify the echocardiographic parameters
associated with outcomes among patients undergoing major
noncardiac surgery.
Methods: A retrospective single-institution investigation
identified 1,770 patients who underwent one or more major
noncardiac procedures from Jan. 1, 2011, to June 30, 2014, and
had at least one TTE performed within 90 days before surgery.
Patients were stratified by presurgery left ventricular ejection
fraction (LVEF) into LVEF ≤ 40% and LVEF > 40% groups. The
cohort was followed through June 12, 2015, with the outcome
focused on all-cause mortality. Continuous and categorical
variables were compared by Student’s t-test and chi-squared
test, respectively. Kaplan-Meier method was used to calculate
mortality estimates postsurgery. Cox proportional hazards model
was used for univariate and multivariable models.
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